TGA Fees and Charges Proposal 2027-28

Issuing BodyTherapeutic Goods Administration (TGA)
Opening Date20/10/2026
Closing Date16/11/2026
StatusOpen
Consultation Websitehttps://consultations.tga.gov.au/regulatory-practice-section/tga-fees-and-charges-proposal-2027-28/

The Therapeutic Goods Administration (TGA) has published a consultation paper outlining proposed fees and charges for 2027-28. The paper has been released to seek broader stakeholder feedback on the proposed changes. The consultation closes on Monday 16 November 2026. Please email any feedback to be included in MTAA’s response to Laila at lwaheed@mtaa.org.au by COB Wednesday 11 November 2026.

Industry Comments

  1. Feedback on the proposal of increasing annual charges to recover the cost of non-mandatory application audits: This proposal appears equitable. As application audits are conducted in relation to new ARTG applications, sponsors of products that are already included in the ARTG should not be required to recover the audit cost associated with new product registrations.

  2. I would like to discuss the arrangements that are proposed on page 9: Recovering the costs of non-mandatory medical device application audits:
    The TGA proposes to increase the annual charges for higher class devices by an additional 5% to cover the costs of non-mandatory audits (which do not incur a cost at the moment). I think that this is the wrong way to go about it:
    1. It unfairly shifts costs to companies that have a lot of devices on the ARTG but no new applications. They do not require non-mandatory audits at all but will be hit with an extra 5% on the annual charges bill.
    2. It sets the wrong incentive for TGA to conduct non-mandatory audits. By having these covered by the annual charges it is almost like a fixed income stream which could prompt the TGA to continue selecting applications for non-mandatory audit (when this should really be the exception). Having no funding for non-mandatory audits instead promotes the TGA only picking applications for non-mandatory audits if there are grave concerns as per the Application Audit Framework.

    1. Agree with Falko’s comments. Perhaps some additional questions for TGA could be:

      1. How has the proposed increase been calculated, including the expected volume and cost of non-mandatory audits?
      2. Why should the cost be recovered through annual charges across existing ARTG entries rather than through applications that generate the audit activity?
      3. Does TGA anticipate any change in the frequency or selection criteria for non-mandatory audits under the proposed funding model?
      4. What safeguards will ensure the new cost-recovery approach does not unintentionally incentivise increased audit activity?
      5. Has TGA considered alternative cost-recovery models, including an audit-specific fee, and what were the reasons for preferring an increase in annual charges?

  3. Stryker would also welcome clarification on the following points:
    1. Could TGA provide further context on why the 5% additional increase in annual charges is being applied across all device classes, noting that non-mandatory audits are typically associated with higher class applications e.g. Class IIb and Class III applications?
    2. The consultation paper describes this as a one-off fee increase. Can TGA provide any indication as to whether further above-CPI increases are anticipated for 2027–28, or whether future increases are expected to return to the usual CPI-based approach?

Search

Consultation Files

Consultation Paper - Fees and Charges FY2027-28Download

You are now subscribed

Thank you for your enquiry. Please check your email to schedule a virtual meeting with the MTAA membership team.

MTAA / RegConnect Membership Enquiry

We respect your privacy. No contact information is shared.